Incyte Pathology, Inc. DBA Incyte Diagnostics
Overview
Incyte Pathology, Inc. DBA Incyte Diagnostics sponsors a self-funded health plan that covered 502 participants in plan year 2025, down 9% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.
- Plan type
- ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
- Participants
- 502 · prior year 550
- Plan year
- Begins January 1 · next renewal January 2027
- Health plans filed
- Incyte Diagnostics Health and Welfare Benefit Plan, plan 501 (502 participants)
- Broker compensation
- $130K across insured contracts
Insurance carriers
Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.
| Carrier | Coverage | Covered | Premium | Broker comp |
|---|---|---|---|---|
| Unum Life Insurance Company of America | Long-term disability, Lifestyle Life, Lifestyle AD&D, Critical Illness, Hospital Indemnity, Short-term disability | 115 | $687K | $106K |
| Delta Dental of Washington | Dental, Vision | 399 | $306K | $17K |
| Willamette Dental of Washington, Inc. | Dental | 78 | $59K | $6K |
| Unum Insurance Company of America | Group Accident | 56 | $20K | $1K |
Pharmacy benefit estimate
StreamRX estimate for a plan this size. Not based on this plan's claims.
Estimated prescription spend: 502 participants × $2,371 national average per member. Usually higher once dependents are counted.
Typical savings opportunity found in independent reviews of plans this size.
Form 5500 filing details
- Filing
- Form 5500 with Schedule A, plan year 2025
- Plan sponsor
- Incyte Pathology, Inc. DBA Incyte Diagnostics
- Sponsor EIN
- 91-0845805
- Plan number
- 501
- Filed with
- U.S. Department of Labor (EBSA) via EFAST2
Verify this filing: search EIN 91-0845805 in the Department of Labor's EFAST2 Form 5500 search.
Retirement plan
- Plan
- Incyte Diagnostics Retirement Plan
- Type
- 401(k) plan
- Participants
- 635
About this data
Source: Incyte Pathology, Inc. DBA Incyte Diagnostics's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Incyte Pathology, Inc. DBA Incyte Diagnostics.